Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Testing effectiveness (Phase 2)Study completedNCT03554083
What this trial is testing

Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+3 more
Mayo Clinic 64
Testing effectiveness (Phase 2)UnknownNCT03992456
What this trial is testing

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more
Academic and Community Cancer Research United 12
Early research (Phase 1)Study completedNCT03784677
What this trial is testing

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00991952
What this trial is testing

Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the StomachIntestinal Adenocarcinoma of the Stomach+6 more
National Cancer Institute (NCI) 19
Very early researchStudy completedNCT03395847
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma

Who this might be right for
Advanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8+22 more
M.D. Anderson Cancer Center 9
Not applicableStudy completedNCT02677389
What this trial is testing

Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin

Who this might be right for
Cancer SurvivorHealthy SubjectStage I Colorectal Cancer+13 more
University of Wisconsin, Madison 100
Not applicableStudy completedNCT01564368
What this trial is testing

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
American College of Radiology Imaging Network 406
Testing effectiveness (Phase 2)Study completedNCT00072176
What this trial is testing

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell Carcinoma+7 more
National Cancer Institute (NCI) 62
Not applicableEnded earlyNCT01222377
What this trial is testing

Endoscopic Breast Surgery in Treating Patients With Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IA Breast Cancer+6 more
University of Southern California 2
Very early researchActive Not RecruitingNCT05041153
What this trial is testing

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaClinical Stage III Gastric Cancer AJCC v8+30 more
M.D. Anderson Cancer Center 15
Not applicableActive Not RecruitingNCT04754412
What this trial is testing

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 256
Very early researchActive Not RecruitingNCT02659241
What this trial is testing

Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Ovarian CarcinomaAdvanced Primary Peritoneal Carcinoma+19 more
M.D. Anderson Cancer Center 38
Early research (Phase 1)Ended earlyNCT00346229
What this trial is testing

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Duke University 29
Not applicableStudy completedNCT01013337
What this trial is testing

Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain

Who this might be right for
Breast CancerRecurrent Breast CancerStage I Breast Cancer+4 more
Abramson Cancer Center at Penn Medicine 76
Very early researchStudy completedNCT03132467
What this trial is testing

Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+14 more
M.D. Anderson Cancer Center 16
Not applicableStudy completedNCT00438477
What this trial is testing

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 74
Not applicableActive Not RecruitingNCT04906200
What this trial is testing

Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more
Ohio State University Comprehensive Cancer Center 400
Testing effectiveness (Phase 2)Study completedNCT02902029
What this trial is testing

Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

Who this might be right for
Malignant Melanoma
University Hospital, Essen 186
Early research (Phase 1)Ended earlyNCT01835184
What this trial is testing

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+3 more
National Cancer Institute (NCI) 5
Next Page